Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Facioscapulohumeral Muscular Dystrophy 1a”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Looking for participantsNCT06131983
What this trial is testing

Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Sarepta Therapeutics, Inc. 60
Not applicableUnknownNCT06517498
What this trial is testing

Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Xi'an Jiaotong University 300
Not applicableStudy completedNCT07331025
What this trial is testing

Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings

Who this might be right for
Facioscapulohumeral Muscular DystrophyFacioscapulohumeral Muscular Dystrophy 1Neuromuscular Disease
Koç University 39
Not applicableLooking for participantsNCT07543016
What this trial is testing

Amino Acids and Exercise in FSHD

Who this might be right for
FSH Muscular DystrophyMuscular Dystrophy
University of Pavia 48
Testing effectiveness (Phase 2)Study completedNCT00104078
What this trial is testing

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyFacioscapulohumeral Muscular DystrophyLimb-Girdle Muscular Dystrophy
Wyeth is now a wholly owned subsidiary of Pfizer 108
Not applicableStudy completedNCT02159963
What this trial is testing

High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Grete Andersen, MD 18
Testing effectiveness (Phase 2)Ended earlyNCT03943290
What this trial is testing

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Who this might be right for
Facioscapulohumeral Muscular DystrophyCharcot-Marie-Tooth Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 62
Early research (Phase 1)Study completedNCT03123913
What this trial is testing

Study of Testosterone and rHGH in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Rochester 20
Not applicableLooking for participantsNCT04001582
What this trial is testing

The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Newcastle University 1,018
Early research (Phase 1)Looking for participantsNCT07086521
What this trial is testing

Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Restem, LLC. 16
Not applicableStudy completedNCT02159612
What this trial is testing

1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Grete Andersen, MD 45
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableLooking for participantsNCT05019625
What this trial is testing

Biomarker Development for Muscular Dystrophies

Who this might be right for
Myotonic DystrophyDuchenne Muscular DystrophyBecker Muscular Dystrophy+1 more
Massachusetts General Hospital 465
Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8
Not applicableStudy completedNCT00004685
What this trial is testing

Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Ohio State University 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT06222827
What this trial is testing

Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Centre Hospitalier Universitaire de Nice 46
Not applicableEnded earlyNCT06096441
What this trial is testing

FSHD Molecular Characterization

Who this might be right for
Facio-Scapulo-Humeral Dystrophy
Nationwide Children's Hospital 1
Testing effectiveness (Phase 2)Ended earlyNCT02927080
What this trial is testing

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 95
Not applicableStudy completedNCT06785428
What this trial is testing

Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Fascioscapulohumeral Muscular Dystrophy
McGill University 10
Next Page